Back to Goldman Sachs Group Inc. Goldman Sachs Group Inc.

PROK

4 quarters

Position history for Goldman Sachs Group Inc.Goldman Sachs Group Inc.'s holdings in ProKidney Corp.

Yes. Goldman Sachs holds 203,006 shares of PROK (ProKidney), worth $414,132, as of its Q2 2026 13F filing. It reduced the position by 218,896 shares (-51.9%) from Q1 2026. Goldman Sachs has held PROK in every 13F on record since Q3 2025, 4 quarterly filings.

Current Value

$414,132

Current Shares

203,006

Total Value Change

+$15,759

Total Shares Change

+38,389

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
203,006
-51.9%
$414,1320.0%$2.04
0
2026-Q1
Decreased
421,902
-38.1%
$755,2040.0%$2.21
0
2025-Q4
Increased
681,161
+313.8%
$1.5M0.0%$2.20
41
2025-Q3
New
164,617
-
$398,3730.0%$2.42
36

Other major holders of PROK: Morgan Stanley, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used